Twitter
Advertisement

Cadila Healthcare Q3 net profit rises 68 pc to Rs 543 cr

Cadila Healthcare today reported 67.73 per cent rise in consolidated net profit at Rs 543.3 crore for the third quarter ended December 31.

Latest News
article-main
FacebookTwitterWhatsappLinkedin

Cadila Healthcare today reported 67.73 per cent rise in consolidated net profit at Rs 543.3 crore for the third quarter ended December 31.

It had posted a net profit of Rs 323.9 crore in the October-December period of the previous fiscal.

Revenue from operations stood at Rs 3,191.8 crore, up 38.63 per cent, against Rs 2,302.3 crore in the same period a year ago, Cadila Healthcare said in a regulatory filing.

The company's stock was trading 2.80 per cent higher at Rs 407.40 on BSE. S

Last year in June, Cadila Healthcare's board has approved raising up to Rs18,500 crore through various financial tools. 

The Pankaj Patel-led company said that its board had considered and granted in-principle approval to various fund raising proposals. However, the company did not reveal how it plans to utilise the funds proposed to be raised.

Drug major Cadila Healthcare, the second most valued pharma company in India with market valuation of Rs 53,750 crore, said on Monday that its board has approved raising up to Rs18,500 crore through various financial tools. 

The Pankaj Patel-led company said in a BSE filing that its board had considered and granted in-principle approval to various fund raising proposals. However, the company did not reveal how it plans to utilise the funds proposed to be raised.

Find your daily dose of news & explainers in your WhatsApp. Stay updated, Stay informed-  Follow DNA on WhatsApp.
Advertisement

Live tv

Advertisement
Advertisement